DRNA Net Margin
As of 2025-07-04, the Net Margin of Dicerna Pharmaceuticals Inc (DRNA) is -68.6%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
DRNA Net Margin - Historical Value
| Date | Value |
|---|---|
| 2020-12-31 | -68.6% |
| 2019-12-31 | -504.2% |
| 2018-12-31 | -1433.9% |
| 2017-12-31 | -6020% |
| 2016-12-31 | -19833.3% |
| 2015-12-31 | -31400% |
| 2014-12-31 | - |
| 2013-12-31 | - |
| 2012-12-31 | -144.3% |
| 2011-12-31 | -108.9% |
DRNA Net Margin - Peers Comparison